QUELIMMUNE

Serial Number 98411109
819

Registration Progress

Application Filed
Feb 19, 2024
Under Examination
Mar 18, 2025
Approved for Publication
Jan 21, 2025
Published for Opposition
Jan 21, 2025
Registered

Trademark Image

QUELIMMUNE

Basic Information

Serial Number
98411109
Filing Date
February 19, 2024
Published for Opposition
January 21, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
819
Status Date
Oct 9, 2025
Application
Pending
Classes
010

Rights Holder

SeaStar Medical, Inc.

03
Address
3513 Brighton Boulevard, Suite 410
Denver, CO 80216

Ownership History

SeaStar Medical, Inc.

Original Applicant
03
Denver, CO

SeaStar Medical, Inc.

Owner at Publication
03
Denver, CO

Legal Representation

Attorney
Carla B. Oakley

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

20 events
Date Code Type Description Documents
Oct 9, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Oct 9, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Sep 18, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 18, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 25, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 25, 2025 IUAF S USE AMENDMENT FILED Loading...
Mar 18, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 21, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 21, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 15, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 30, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 11, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Dec 10, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 10, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 11, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 11, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 11, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 10, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 24, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 19, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 010
Selective cytopheretic devices, namely medical devices used to treat conditions caused by a dysregulated immune response by selectively binding certain activated white blood cells, reducing their inflammatory state, and releasing the modified blood cells back into the blood.
First Use Anywhere: Jul 31, 2024
First Use in Commerce: Jul 31, 2024

Additional Information

Translation
The wording "Quelimmune" has no meaning in a foreign language.

Classification

International Classes
010